Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder

39Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims: To investigate dexamphetamine transfer into milk, infant doses and effects in the breast-fed infant. Methods: Four women taking dexamphetamine, and their infants were studied. Results: The median maternal dexamphetamine dose was 18 mg day-1 (range 15-45 mg day-1). Median (interquartile range) descriptors were 3.3 (2.2-4.8) for milk/plasma ratio, 21 μg kg-1 day-1 (11-39) for absolute infant dose and 5.7% (4-10.6%) for relative infant dose. No adverse effects were seen. In three infants tested, dexamphetamine in plasma was undetected in one (limit of detection 1 μg l-1) and present at 18 μg l-1 and 2 μg l-1 in the other two. Conclusion: Dexamphetamine readily transfers into milk. The relative infant dose was <10% and within a range that is generally accepted as being 'safe' in the short term. © 2006 The Authors.

Cite

CITATION STYLE

APA

Ilett, K. F., Hackett, L. P., Kristensen, J. H., & Kohan, R. (2007). Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder. British Journal of Clinical Pharmacology, 63(3), 371–375. https://doi.org/10.1111/j.1365-2125.2006.02767.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free